In February 2021, Andreas was appointed Commercial lead for the SEA Cluster (South, East and Southeast Asia) in Organon, which is a spinoff of MSD, focused on women’s health.

From 2012-2021 Andreas has held positions of increasing seniority in MSD. He started his career in the biopharma industry in MSD Denmark as Health Economist and his final position was Managing Director of MSD in Denmark and Iceland. In Denmark he held board positions in the pharmaceutical industry association (LIF), American Chamber of Commerce, Denmark (Amcham) and a Market Intelligence corporation (DLI & DLI/MI).

In between his roles in Denmark, Andreas had commercial leadership roles in the US, Nordic Cluster and Netherlands.